Khiron Life Sciences Corp.
Rank 48
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$2.91
USD
-2.72%
Market cap
$224,927,309
Total volume
$5,881,078
Shares outstanding
89,374,662
Rank 48
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$4,606,697
|
78.33% |
$2.91
|
| KHRNF |
Total volume
$1,274,381
|
21.67% |
Stock price
$2.90
|
Chart